You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Toward urinary catheterization with long-term resistance to bacterial colonization
SBC: WYNNVISION LLC Topic: 400PD/PI Kennard Brunson Project Summary Toward urinary catheterization with long-term resistance to bacterial colonization Problem: Catheter Associated Urinary Tract Infections (CAUTI) are one of the most common infections in hospitals and health care facilities. A study of urinary catheterisation involving over 9 million hospitalized patients found 12.9% were catheterised overall, but 72.9% were ca ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Beacon-OUD: Behavioral Economic Screening Tool of Opioid Use Disorder for Use in Clinical Practice
SBC: BEAM Diagnostics, Inc. Topic: NIDAPROJECT SUMMARY Opioid use disorder (OUD) is a major contributor to excessive disability, morbidity, and mortality in the United States. Currently, almost 10 million Americans misuse opioid substances and 2.7 million Americans suffer from OUD. In the past year alone, U.S. opioid overdose deaths have increased by nearly 30%, resulting in an annual mortality rate of rt100,000, akin to a death every ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
A youth-specific helmet for preventing traumatic brain injury
SBC: SAVIOR BRAIN INC. Topic: 102PROJECT SUMMARY Savior Brain’s SoftShox is the world’s first wearable hydraulic shock absorber. SoftShox uses liquid momentum transfer to dissipate impact energy, resulting in dramatically reduced linear and rotational forces for a given impact event. Brain injuries, including nearly 4 million concussions per year, are common among the nearly 40 million participants in organized youth sports i ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
IND Enabling Studies for the Development of NASH Therapeutic TB-019
SBC: TAMUROBIO INC Topic: 300SUMMARY Nonalcoholic steatohepatitis (NASH) is a significant, worldwide health problem affecting an estimated 14 million people in the US. It is characterized by hepatic inflammation and injury and fibrosis. Subjects diagnosed with NASH are at significantly increased risk of morbidity and mortality due to cirrhosis, and hepatocellular carcinoma. Without any currently available FDA approved treatme ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel therapeutic approach for severe ARDS with a potent pharmacologic allosteric hemoglobin modifier
SBC: IllExcor Therapeutics LLC Topic: NHLBIAcute respiratory distress syndrome (ARDS) is a life-threatening condition featuring acute onset of non- cardiogenic respiratory failure and hypoxemia. Consequently, patients with ARDS have severe hypoxemia due to a significant impairment of gas exchange, and the goal of supportive therapy is to prevent critical tissue hypoxia, which can cause acute cardiac arrest and death or have long-term neuro ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Educational Media to Promote healthcare Awareness through an Immersive Experience (EMPATHIE)
SBC: BARRON ASSOCIATES, INC. Topic: 500PROJECT SUMMARY/ABSTRACT Significance: EMPATHIE is a unique learning system that introduces healthcare and science concepts in an imaginative and engaging platform. The system combines an innovative motion-based game interface with software that provides an immersive experience into motor control disorders and promotes inquiry-based challenges. Importantly, lesson modules are presented to the stud ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Respiratory Oxygen Adherence Monitor for COPD Patients
SBC: BARRON ASSOCIATES, INC. Topic: NHLBIPROJECT SUMMARY/ABSTRACT Introduction: The Respiratory Oxygen Adherence Monitor (ROAM) system will provide an effective, practical, and affordable method to reliably assess and improve long-term-oxygen therapy (LTOT) adherence. Problem to be Addressed: Chronic obstructive pulmonary disease (COPD) over 15 people in the United States; the condition causes more than 500,000 hospitalizations and over ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel whole-genome analysis methods for Alzheimer's risk prediction
SBC: PARABON NANOLABS, INC. Topic: RPROJECT SUMMARYAlzheimer’s Disease (AD) affects millions of Americans, yet there are no treatments that meaningfully affect disease progression once symptoms manifest. This has shifted the focus to early detection and intervention, which is thought by many researchers to offer the best chance of slowing or stopping the progression of AD. However, trials aimed at averting the underlying causes of ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Clinical evaluation of a commercially viable machine learning algorithm to automatically detect shoulder muscle pathology
SBC: SPRINGBOK INC Topic: NIAMSPROJECT SUMMARY Rotator cuff repairs are amongst the most performed orthopedic surgeries (rt400,000 surgeries in the US per year) but remain a very challenging clinical problem. While surgical repair of the rotator cuff seeks to improve shoulder function and stability, the surgical outcomes vary significantly because, pre-operatively, it is difficult under current evaluative methods to predict whi ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Targeting galectin-3 to overcome insulin resistance in type 2 diabetes
SBC: GLYCOMANTRA INC Topic: 200Project Summary/Abstract Obesity-mediated insulin resistance is a hallmark of type 2 diabetes (T2D), which accounts for ~90% of all diabetes. Despite many drugs that are available to treat T2D, there is no FDA-approved drug that directly works on the insulin receptor (IR) to overcome insulin resistance. Recent studies show that galectin-3 (Gal3) can bind directly to the IR and inhibit downstream I ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health